BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19404287)

  • 1. Is standard GLA gene mutation analysis definitive for the diagnosis of Fabry disease?
    Mignani R; Morrone A
    Kidney Int; 2009 May; 75(10):1115-6; author reply 1115. PubMed ID: 19404287
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of a novel mutation in the alpha-galactosidase A gene in patients with Fabry disease.
    Colomba P; Nucera A; Zizzo C; Albeggiani G; Francofonte D; Iemolo F; Tuttolomondo A; Pinto A; Duro G
    Clin Biochem; 2012 Jul; 45(10-11):839-41. PubMed ID: 22465271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation of α-galactosidase A gene causes Fabry disease mimicking primary erythromelalgia in a Chinese family.
    Ge W; Wei B; Zhu H; Miao Z; Zhang W; Leng C; Li J; Zhang D; Sun M; Xu X
    Int J Neurosci; 2017 May; 127(5):448-453. PubMed ID: 27211852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutant mRNA expression in an endomyocardial biopsy sample obtained from a patient with a cardiac variant of Fabry disease caused by a novel acceptor splice site mutation in the invariant AG of intron 5 of the α-galactosidase A gene.
    Watanabe T; Hanawa H; Suzuki T; Jiao S; Yoshida K; Ogura M; Ohno Y; Hayashi Y; Ito M; Kashimura T; Obata H; Sato A; Ozawa T; Kodama M; Sakuraba H; Minamino T
    Intern Med; 2013; 52(7):777-80. PubMed ID: 23545674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel small insertion mutation, C.1030_1031ins (T) in α-galactosidase A leads to renal variant fabry disease.
    Choi JS; Kim CS; Park JW; Bae EH; Ma SK; Choi YD; Kim GH; Yoo HW; Kim SW
    Ren Fail; 2012; 34(3):390-3. PubMed ID: 22260214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography.
    Shabbeer J; Robinson M; Desnick RJ
    Hum Mutat; 2005 Mar; 25(3):299-305. PubMed ID: 15712228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease.
    Duro G; Musumeci MB; Colomba P; Zizzo C; Albeggiani G; Mastromarino V; Volpe M; Autore C
    Gene; 2014 Feb; 535(2):365-9. PubMed ID: 24140492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel human pathological mutations. Gene symbol: GLA. Disease: Fabry disease.
    Ferreira S; Valbuena C; Carvalho F; Oliveira JP
    Hum Genet; 2009 Aug; 126(2):352. PubMed ID: 19694060
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of novel mutations in the α-galactosidase A gene in patients with Fabry disease: pitfalls of mutation analyses in patients with low α-galactosidase A activity.
    Yoshimitsu M; Higuchi K; Miyata M; Devine S; Mattman A; Sirrs S; Medin JA; Tei C; Takenaka T
    J Cardiol; 2011 May; 57(3):345-53. PubMed ID: 21333496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of alpha-galactosidase a gene in Hungarian Fabry patients.
    László A; Török L; Raffai S; Török E; Sallay E; Endreffy E; Morvai L; van Amstel JK
    Ideggyogy Sz; 2012 Jan; 65(1-2):35-9. PubMed ID: 22338844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene symbol: GLA.
    Spanu C; Lekanne dit Deprez RH; Groener JE; Nita CC
    Hum Genet; 2007 Apr; 121(2):295. PubMed ID: 17598215
    [No Abstract]   [Full Text] [Related]  

  • 12. Fabry disease previously diagnosed as Henoch-Schonlein purpura.
    Kim JH; Han DH; Park MY; Choi SJ; Kim JK; Hwang SD; Jin SY
    Korean J Intern Med; 2015 Nov; 30(6):925-7. PubMed ID: 26552470
    [No Abstract]   [Full Text] [Related]  

  • 13. Fabry disease in patients with end-stage renal failure: the potential benefits of screening.
    Bekri S; Enica A; Ghafari T; Plaza G; Champenois I; Choukroun G; Unwin R; Jaeger P
    Nephron Clin Pract; 2005; 101(1):c33-8. PubMed ID: 15886492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New mutations in the GLA gene in Brazilian families with Fabry disease.
    Turaça LT; Pessoa JG; Motta FL; Muñoz Rojas MV; Müller KB; Lourenço CM; Junior Marques W; D'Almeida V; Martins AM; Pesquero JB
    J Hum Genet; 2012 Jun; 57(6):347-51. PubMed ID: 22551898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First Reported Case of Fabry Disease Caused by a Somatic Mosaicism in the GLA Gene.
    Barriales-Villa R; Ochoa JP; Santomé-Collazo JL; Mosquera-Reboredo J; Cao-Vilariño M; Monserrat L
    Rev Esp Cardiol (Engl Ed); 2019 Jul; 72(7):585-587. PubMed ID: 30029973
    [No Abstract]   [Full Text] [Related]  

  • 16. Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease.
    Schäfer E; Baron K; Widmer U; Deegan P; Neumann HP; Sunder-Plassmann G; Johansson JO; Whybra C; Ries M; Pastores GM; Mehta A; Beck M; Gal A
    Hum Mutat; 2005 Apr; 25(4):412. PubMed ID: 15776423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of GLA gene deletions in Fabry patients by Multiplex Ligation-dependent Probe Amplification (MLPA).
    Schirinzi A; Centra M; Prattichizzo C; Gigante M; De Fabritiis M; Giancaspro V; Petrarulo F; Santacroce R; Margaglione M; Gesualdo L; Ranieri E
    Mol Genet Metab; 2008 Jul; 94(3):382-5. PubMed ID: 18472290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alpha-galactosidase A gene mutation in a Chinese family with Fabry disease mimicking clinical features of hypertrophic cardiomyopathy].
    Liu HJ; Cao KJ; Li CR; Dai J; Ma JZ; Yong YH; Sun W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Feb; 34(2):143-7. PubMed ID: 16626582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation the alternative splicing of GLA (IVS4+919G>A) in Fabry disease.
    Chang WH; Niu DM; Lu CY; Lin SY; Liu TC; Chang JG
    PLoS One; 2017; 12(4):e0175929. PubMed ID: 28430823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel acceptor splice site mutation in the invariant AG of intron 6 of alpha-galactosidase A gene, causing Fabry disease. Mutations in brief no. 146. Online.
    Matsumura T; Osaka H; Sugiyama N; Kawanishi C; Maruyama Y; Suzuki K; Onishi H; Yamada Y; Morita M; Aoki M; Kosaka K
    Hum Mutat; 1998; 11(6):483. PubMed ID: 10200059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.